Allarity Therapeutics (ALLR) Treasury Shares (2022 - 2026)
Allarity Therapeutics' (ALLR) quarterly Treasury Shares came in at $3.2 million in Q1 2026, up 331.53% YoY from $744709.0 in Q1 2025, and up 418.19% on a QoQ basis from $620164.0 in Q4 2025.
Allarity Therapeutics (ALLR) Treasury Shares (2022 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 5 years of Treasury Shares data on file, last reported at $3.2 million in Q1 2026.
- Quarterly Treasury Shares rose 331.53% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 331.53% YoY) and the FY2025 annual result came in at $2.9 million, up 1594.82% from the prior year.
- Treasury Shares rose to $3.5 million in Q1 2026, from $3.2 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $3.2 million in Q1 2026 to a low of $1550.0 in Q2 2023.
- A 5-year average of $833213.5 and a median of $174038.0 in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares slumped 44.28% — and 2024, when it soared 3658.92%.
- Tracing ALLR's Treasury Shares over 2 years: stood at $3.2 million in 2025, then climbed by 8.21% to $3.5 million in 2026.
- The last three Treasury Shares figures came in at $3.5 million (Q1 2026), $3.2 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | 3.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.21 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Mar 31, 2026 | 3.21 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Dec 31, 2025 | 3.19 Mn |
| Dec 31, 2025 | 620,164.00 |
| Dec 31, 2025 | 3.19 Mn |
| Dec 31, 2025 | 620,164.00 |
| Sep 30, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 744,709.00 |
| Mar 31, 2025 | 744,709.00 |
| Dec 31, 2024 | 174,038.00 |
| Dec 31, 2024 | 174,038.00 |